preview

Non Pharmacologic Interventions For Newborns With Neonatal Abstinence Syndrome

Better Essays

Non-Pharmacologic Interventions for Newborns with Neonatal Abstinence Syndrome Meghan Pasternak 0496981 Dr. Karen McQueen NURS 2030 Lakehead University January 5, 2015 Problematic substance use in pregnancy is prevalent among the Canadian population. The statistics are well documented in the literature. According to a Health Quality Ontario report from 2012, about one in 100 pregnant women giving birth in Ontario hospitals shows substance use. The rate of substance abuse among pregnant women has increased since 2009 by about ten percent. Dow et al. (2012) identify that the management of substance use is particularly problematic in Northern Ontario. Many First Nations communities are in a state of emergency regarding abuse of prescription narcotics (Dow et al., 2012, p. 489). Substance abuse has a profound effect on a woman and her newborn baby whose drug withdrawal manifests itself as neonatal abstinence syndrome or NAS (Dow et al., 2012, p. 488). MacMullen, Dulski & Blobaum (2014) describe NAS as “a group of similar behavioural signs and symptoms in the neonate caused by withdrawal from various pharmacologic agents” (p. 165). Infants who were exposed to opioids such as morphine, methadone, codeine, oxycodone and heroine in utero experience NAS (Dow et al., 2012, p. 489). The way the syndrome presents itself is unpredictable. Neonates will display different symptoms with varying severity over time (Bagley, Wachman, Holland & Brogly, 2014, p.

Get Access